SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS
LOE Approachingperfluoropolymethylisopropyl ether; polytetrafluoroethylene
NDATOPICALPASTEPriority Review
Approved
Feb 2000
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 2d ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
This is a topical paste formulation containing perfluoropolymethylisopropyl ether and polytetrafluoroethylene, designed to reduce skin exposure to chemical warfare agents. The product functions as a protective barrier rather than a systemic pharmaceutical agent. It was approved in February 2000 for specialized defense and occupational safety applications.
LOE Approaching
This is a niche defense/occupational product with limited commercial scale; career growth is constrained by narrow patient population and government procurement channels.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Career opportunities on this product are limited; linked job count is zero, reflecting niche market status and government-driven demand. Roles focus on regulatory maintenance, government relations, and logistics rather than commercial growth or clinical development.
Government Affairs ManagerSupply Chain/Procurement Specialist
Worked on SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS at Medica Corp? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.